Published by Josh White on 17th April 2023
(Sharecast News) - Life sciences company Ondine Biomedical reported a number of operational highlights in a first-quarter update on Monday, including clinical developments for US market approval, additional clinical data and endorsements, and commercial progress.
URL: http://www.digitallook.com/dl/news/story/33438603/...